Sees Biohaven's JPM Healthcare update as promising for a long-term play.
BHVN — LONG The author views Biohaven's update at the JPM Healthcare conference as a promising catalyst for a long-term position, suggesting the company's prospects are improving despite a series of recent misses. No specific business mechanism or risk is stated beyond the recent disappointments.
BHVN update at JPM HC looks very promising for a long term play.